Published in the Journal of the National Cancer Institute by researchers in the United States, this study identified specific markers of cellular aging – such as DNA damage, cellular senescence, and inflammatory pathways – in all breast cancer survivors, regardless of which treatment they had received.
The study showed that not only toxic chemotherapy drugs but also radiation and surgery can trigger biological aging markers. As a result of these treatments, cellular senescence – where cells stop dividing but don’t die – accumulates, leading to inflammation and damage to nearby cells. This then contributes to the development of conditions such as fatigue, cognitive decline, frailty, and cardiovascular disease.
To read how research carried out in the UK has found that, in some hospitals, within 30 days of starting treatment, chemotherapy kills up to 50 per cent of patients who receive it, see this article on our website.
To learn about Dr. Rath’s scientific approach to the prevention and control of cancer, see this page on our website.
GlaxoSmithKline to Pay $2.2 Billion Over Zantac Cancer Claims
October 18, 2024Vitamin C Deficiency in Senior Citizens Increases Risk of Bleeding and Fatigue
October 18, 2024Study Finds Common Breast Cancer Treatments May Speed Aging Process
News
A new study has revealed that common breast cancer treatments, including chemotherapy, radiation, and surgery, may accelerate the biological aging process in breast cancer survivors.
[Source: medicalxpress.com]
[Image source: Adobe Stock]
Comment
Published in the Journal of the National Cancer Institute by researchers in the United States, this study identified specific markers of cellular aging – such as DNA damage, cellular senescence, and inflammatory pathways – in all breast cancer survivors, regardless of which treatment they had received.
The study showed that not only toxic chemotherapy drugs but also radiation and surgery can trigger biological aging markers. As a result of these treatments, cellular senescence – where cells stop dividing but don’t die – accumulates, leading to inflammation and damage to nearby cells. This then contributes to the development of conditions such as fatigue, cognitive decline, frailty, and cardiovascular disease.
To read how research carried out in the UK has found that, in some hospitals, within 30 days of starting treatment, chemotherapy kills up to 50 per cent of patients who receive it, see this article on our website.
To learn about Dr. Rath’s scientific approach to the prevention and control of cancer, see this page on our website.
Dr. Rath Health Foundation
Related posts
Prenatal B12 Deficiency May Negatively Impact Child Speech and IQ
Read more